These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16633364)

  • 1. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.
    Shang Y
    Nat Rev Cancer; 2006 May; 6(5):360-8. PubMed ID: 16633364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
    Wu H; Chen Y; Liang J; Shi B; Wu G; Zhang Y; Wang D; Li R; Yi X; Zhang H; Sun L; Shang Y
    Nature; 2005 Dec; 438(7070):981-7. PubMed ID: 16355216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormones and cancer.
    Shang Y
    Cell Res; 2007 Apr; 17(4):277-9. PubMed ID: 17426695
    [No Abstract]   [Full Text] [Related]  

  • 4. Extracellular matrix integrity: a possible mechanism for differential clinical effects among selective estrogen receptor modulators and estrogens?
    Cox DA; Helvering LM
    Mol Cell Endocrinol; 2006 Mar; 247(1-2):53-9. PubMed ID: 16426741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
    Flamini MI; Sanchez AM; Goglia L; Tosi V; Genazzani AR; Simoncini T
    Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endometrial effects of SERMs.
    Cano A; Hermenegildo C
    Hum Reprod Update; 2000; 6(3):244-54. PubMed ID: 10874569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
    Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.
    Vessières A; Top S; Beck W; Hillard E; Jaouen G
    Dalton Trans; 2006 Jan; (4):529-41. PubMed ID: 16402138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and SERMs in coronary heart disease.
    Regitz-Zagrosek V; Wintermantel TM; Schubert C
    Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tamoxifen and endometrial cancer].
    Salamanca-Gómez F
    Gac Med Mex; 2006; 142(2):171-2. PubMed ID: 16711554
    [No Abstract]   [Full Text] [Related]  

  • 12. [Selective estrogen receptor modulators (SERMs)].
    Matsumoto T
    Clin Calcium; 2006 Sep; 16(9):1520-25. PubMed ID: 16951478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy.
    Cohen I
    Maturitas; 2008 Jan; 59(1):99-100. PubMed ID: 18162338
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
    Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of breast cancer with selective oestrogen-receptor modulators.
    Jordan VC
    Nat Rev Cancer; 2007 Jan; 7(1):46-53. PubMed ID: 17186017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal therapy for postmenopausal breast cancer: the science of sequencing.
    Miller WR; Bartlett JM; Canney P; Verrill M
    Breast Cancer Res Treat; 2007 Jun; 103(2):149-60. PubMed ID: 17039263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of breast cancer using selective oestrogen receptor modulators (SERMs).
    Powles TJ
    Breast Cancer Res; 2006; 8(5):111. PubMed ID: 17049068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.